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Related research by Sun et al., http://www.alzres.com/content/7/1/65Sun et al. [1] evaluated the association between dental
amalgam fillings and Alzheimer’s disease (AD) in a large
scale Taiwanese population aged 65 years and older in a
cross-sectional study and concluded that women’s ex-
posure to amalgam was significantly associated with AD.
Their findings, as the first data from a population-based
study, are valuable while a previous retrospective cohort
study in New Zealand could not investigate the associ-
ation between dental amalgam exposure and AD due to
insufficient cases [2].
In comparison with previous studies which indicated
higher mercury concentrations in serum and cerebro-
spinal fluid samples of living and brain samples of de-
ceased patients with Alzheimer’s disease [3, 4], Sun et al.
exclusively assessed epidemiologic variables based on the
Longitudinal Health Insurance Database. Several aspects
of the results of their study need to be interpreted with
caution due to their cross-sectional study design, and
multiple limitations affected the power of study. Firstly,
the duration of National Health Insurance (NHI) cover-
age since 2001 would include patients in their sixth and
seventh decades but the pathophysiology of AD may
have started much earlier. On the other hand, they men-
tion that actual fillings were underestimated during the
patients’ life-times but this fact also existed for non-AD
participants because most of the dental preservation
procedures were performed during their youth to middle
age. Although they considered multiple face amalgam
restorations based on the different NHI codes, they did
not differentiate between single and multiple fillings and
unfortunately there was no specific analysis of whether
there is a difference between single versus multiple-
surface amalgam restoration or not. On the other hand,
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Altogether, they describe well their limitations in such
an epidemiological study but, according to what they
found, future investigations are needed to definitively
explore the association between AD and amalgam by
evaluating the duration of exposure to amalgam, consider-
ing the number of dental fillings, the size of restorations
and the covering surface area and other probable risk
factors that play roles in the pathophysiology of AD.
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